Utility of a Novel Clinical Triad (Chandrans TRIAD) for Early Diagnosis of Autoimmune Encephalitis (AIE) in Patients with Progressive Cognitive Decline
{"title":"Utility of a Novel Clinical Triad (Chandrans TRIAD) for Early Diagnosis of Autoimmune Encephalitis (AIE) in Patients with Progressive Cognitive Decline","authors":"T. Issac","doi":"10.35248/2329-8847.9.S4.002","DOIUrl":null,"url":null,"abstract":"Autoimmune Encephalitis (AIE) often presents with cognitive and behavioural symptoms often mimickingprogressive degenerative dementias. Early identification of these potentially reversible conditions can improve patientoutcomes, reduce caregiver burden and promote cost effectiveness. The clinical trial of symptoms namely panicattacks, catatonia and day time sleepiness is often associated with anti N-methyl D-aspartate (NMDA) receptormediated encephalitis and the former two symptoms along with seizures is suggestive of anti-Voltage Gated PotassiumChannel (VGKC) receptor mediated encephalitis. This triad serves as a pragmatic tool to easily identify AIE and alsohelps to distinguish between the two conditions.","PeriodicalId":90884,"journal":{"name":"Journal of aging science","volume":"1 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of aging science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2329-8847.9.S4.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Autoimmune Encephalitis (AIE) often presents with cognitive and behavioural symptoms often mimickingprogressive degenerative dementias. Early identification of these potentially reversible conditions can improve patientoutcomes, reduce caregiver burden and promote cost effectiveness. The clinical trial of symptoms namely panicattacks, catatonia and day time sleepiness is often associated with anti N-methyl D-aspartate (NMDA) receptormediated encephalitis and the former two symptoms along with seizures is suggestive of anti-Voltage Gated PotassiumChannel (VGKC) receptor mediated encephalitis. This triad serves as a pragmatic tool to easily identify AIE and alsohelps to distinguish between the two conditions.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
